APhA Pharmacy Law Matters: Legal and regulatory developments affecting pharmacy in 2018

Activity Preview

This article, which is current as of November 2018, describes federal legislative and regulatory activities in 2018 affecting pharmacy practice, including new and proposed policy changes and other actions stemming from preexisting policy. As always, APhA has advocated aggressively on behalf of pharmacists, student pharmacists, and pharmacy technicians, educating public- and private-sector decision makers about the value of pharmacists’ services and the role of pharmacists and pharmacy technicians in improving patient care.

Learning Objectives

At the completion of this activity, the pharmacist will be able to:

1. Discuss pharmacy provider status activities taking place in 2018.
2. Analyze legislation in 2018 impacting pharmacy practice.
3. Explain how select federal agency actions will affect or are affecting pharmacy practice.

Activity type: Knowledge-based

Target Audience: Pharmacists 

Learning level: 1

Accreditation Information

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  This activity is approved for 2.0 contact hours of CPE credit (0.20 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-19-107-H03-P/T.

To obtain credit for Legal and regulatory developments affecting pharmacy in 2018 complete the assessment with a grade of 70% or better, complete the evaluation, and then claim credit. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.

APhA's continuing pharmacy education policy allows two opportunities to successfully complete the continuing pharmacy education assessment. Please note that the questions may not appear in the same order as printed and only two attempts to pass the assessment will be granted.  The current policy of the APhA Education Department is to not release the correct answers to any of our CPE tests. This policy is intended to maintain the integrity of the CPE activity and the assessment.

Initial release date: January 1, 2019
Expiration date: January 1, 2022 - NO CREDIT GRANTED AFTER THIS DATE

Development

Legal and regulatory developments affecting pharmacy in 2018 is a home-study continuing education activity for pharmacists developed by the American Pharmacists Association.

Advisory Board

Michael A. Mone, BSPharm, JD
Vice President, Associate General Counsel for Regulatory Affairs, Cardinal Health
Geoff Mospan, PharmD
Assistant Professor of Pharmacy, Wingate University, and American Society for Pharmacy Law
Stacie Maass, BSPharm, JD
Senior Vice President, Pharmacy Practice and Government Affairs, APhA
Alicia Kerry Mica
Senior Lobbyist, APhA
Michael Baxter
Director, Regulatory Affairs, APhA
Jenna Ventresca, JD
Director, Health Policy, APhA

Disclosures

APhA’s Government Affairs and editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For complete staff disclosures, please see the Education and Accreditation Information section at www.pharmacist.com/apha-disclosures.

Fee

There is no fee associated with this activity for members of the American Pharmacists Association. There is a $25 fee for nonmembers.

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website and view the Technology System Requirements to have a positive learning experience.